Access the full text.
Sign up today, get DeepDyve free for 14 days.
Richard Kravitz (2000)
Direct-to-consumer advertising of prescription drugs.The Western journal of medicine, 173 4
Ellen Hoen (1998)
Direct-to-consumer advertising: for better profits or for better health?American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 55 6
M. Hollon (1999)
Direct-to-consumer marketing of prescription drugs: creating consumer demand.JAMA, 281 4
J. Avorn (2003)
Advertising and prescription drugs: promotion, education, and the public's health.Health affairs, Suppl Web Exclusives
C. Lewis (2003)
The impact of direct-to-consumer advertising.FDA consumer, 37 2
M. Wilkes, R. Bell, R. Kravitz (2000)
Direct-to-consumer prescription drug advertising: trends, impact, and implications.Health affairs, 19 2
M. Ziegler, Pauline Lew, Brian Singer (1995)
The accuracy of drug information from pharmaceutical sales representatives.JAMA, 273 16
E. Batchlor, M. Laouri (2003)
Pharmaceutical promotion, advertising, and consumers.Health affairs, Suppl Web Exclusives
J. Jeffords (2004)
Direct-to-consumer drug advertising: you get what you pay for.Health affairs, Suppl Web Exclusives
S.D. Allison‐Ottey, K. Ruffin, K.B. Allison
‘To do no harm’: survey of NMA physicians regarding perceptions on DTC advertisements
S. Wolfe (2002)
Direct-to-consumer advertising--education or emotion promotion?The New England journal of medicine, 346 7
G. Beringer (1914)
American Pharmaceutical Association: Organized 1851. Incorporated 1888Journal of the American Pharmaceutical Association, 3
J. Calfee (2003)
What do we know about direct-to-consumer advertising of prescription drugs?Health affairs, Suppl Web Exclusives
S. Woloshin, Lisa Schwartz, H. Welch (2004)
The value of benefit data in direct-to-consumer drug ads.Health affairs, Suppl Web Exclusives
L. Fintor (2002)
Direct-to-consumer marketing: how has it fared?Journal of the National Cancer Institute, 94 5
P. Mansfield, B. Mintzes, D. Richards, L. Toop (2004)
Direct to consumer advertisingBMJ : British Medical Journal, 330
R. Bell, R. Kravitz, M. Wilkes (1999)
Direct-to-consumer prescription drug advertising and the publicJournal of General Internal Medicine, 14
M. Rosenthal, E. Berndt, J. Donohue, R. Frank, A. Epstein (2002)
Promotion of prescription drugs to consumers.The New England journal of medicine, 346 7
W.L. Bonifazi
Hard sell: drug makers are spending billions on direct‐to‐consumer ads, but just how effective are the products?
Pat Kelly (2004)
DTC advertising's benefits far outweigh its imperfections.Health affairs, Suppl Web Exclusives
S. Petroshius, Philip Titus, Kathryn Hatch (1995)
Physician attitudes toward pharmaceutical drug advertisingJournal of Advertising Research, 35
M. Lipsky, Christine Taylor (1997)
The opinions and experiences of family physicians regarding direct-to-consumer advertising.The Journal of family practice, 45 6
R. Dubois (2003)
Pharmaceutical promotion: don't throw the baby out with the bathwater.Health affairs, Suppl Web Exclusives
R. Bell, M. Wilkes, R. Kravitz (2000)
The educational value of consumer-targeted prescription drug print advertising.The Journal of family practice, 49 12
D. Kessler, W. Pines (1990)
The federal regulation of prescription drug advertising and promotion.JAMA, 264 18
H. Waxman (2004)
Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?Health affairs, Suppl Web Exclusives
S. Allison-Ottey, K. Ruffin, Kimberly Allison (2002)
"To do no harm" survey of NMA physicians regarding perceptions on DTC advertisements. National Medical Association.Journal of the National Medical Association, 94 4
J. Avorn, M. Chen, R. Hartley (1982)
Scientific versus commercial sources of influence on the prescribing behavior of physicians.The American journal of medicine, 73 1
R. Dubois, E. Batchlor, S. Wade (2002)
Geographic variation in the use of medications: is uniformity good news or bad?Health affairs, 21 1
American Pharmaceutical Association
Navigating the Medication Marketplace: How Consumers Choose
J. Weissman, D. Blumenthal, A. Silk, Michael Newman, K. Zapert, R. Leitman, Sandra Feibelmann (2004)
Physicians report on patient encounters involving direct-to-consumer advertising.Health affairs, Suppl Web Exclusives
D.W. Carlton, J.M. Perloff
Advertising and disclosure
E. Cohen (1988)
Direct-to-the-public advertisement of prescription drugs.The New England journal of medicine, 318 6
R. Dubois, C. Alexander, S. Wade, A. Mosso, L. Markson, J. Lu, Soma Nag, M. Berger (2002)
Growth in use of lipid-lowering therapies: are we targeting the right patients?The American journal of managed care, 8 10
Purpose – The purpose of this study is to provide an overview of the economic and clinical impacts of direct‐to‐consumer (DTC) advertising on consumers and physicians.Design/methodology/approach – Controversy around the benefits and concerns associated with DTC advertising are summarized. The sources are sorted based on their position toward DTC promotions: defending or opposing. Two recent works by Woloshin et al. and by Weisseman et al. are discussed in depth to provide the empirical evidence for the impacts of DTC promotions.Findings – Notwithstanding many concerns against DTC advertising, evidence‐based papers report that both consumers and physicians are potentially benefited from it. Consumers rate the health‐related information contained in DTC advertising as important. Physicians do not feel that they are pressured to prescribe inappropriate medications driven by DTC advertising. Physicians perceive improved communication and education among DTCA‐influenced patients. However, consumers tend to overestimate drug effectiveness when the ads vaguely convey the benefit information and subsequently, seek unnecessary treatments. DTC advertising needs to be required to demonstrate the benefit information using actual data. This will help consumers avoid overuse of drugs.Originality/value – This paper recognizes DTC advertising as a positive force for the public health and at the same time identifies its potential negative effects on the economic and clinical aspects of the health care markets. This can offer practical help policymakers develop the effective regulations on DTC advertisings to reinforce the beneficial outcome while attenuating the potential harms that might take place.
Journal of Consumer Marketing – Emerald Publishing
Published: Dec 1, 2005
Keywords: Medical prescriptions; Advertising; Drugs; Consumers
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.